PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsmucopolysaccharidosis ii
MeSH D016532 - mucopolysaccharidosis ii
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D038901:X-linked mental retardation
0 Companies
0 Drugs
Success rate
D009083:Mucopolysaccharidoses
0 Companies
0 Drugs
Success rate
D016532: 
Mucopolysaccharidosis ii
$
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TakedaIdursulfase Elaprase  2006-07-24   
Clinical Trials
Historical Success Rate
Phase 1
100%
5/5
Phase 2
29%
4/14
Phase 3
71%
5/7
Approved: 3Overall Success rate: 20%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Takeda
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use